110 related articles for article (PubMed ID: 9282781)
1. High level expression of equine herpesvirus 1 glycoproteins D and H and their role in protection against virus challenge in the C3H (H-2Kk) murine model.
Stokes A; Cameron RS; Marshall RN; Killington RA
Virus Res; 1997 Aug; 50(2):159-73. PubMed ID: 9282781
[TBL] [Abstract][Full Text] [Related]
2. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
[TBL] [Abstract][Full Text] [Related]
3. The production of a truncated form of baculovirus expressed EHV-1 glycoprotein C and its role in protection of C3H (H-2Kk) mice against virus challenge.
Stokes A; Alber DG; Cameron RS; Marshall RN; Allen GP; Killington RA
Virus Res; 1996 Oct; 44(2):97-109. PubMed ID: 8879139
[TBL] [Abstract][Full Text] [Related]
4. Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model.
Tewari D; Whalley JM; Love DN; Field HJ
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1735-41. PubMed ID: 8021602
[TBL] [Abstract][Full Text] [Related]
5. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).
Osterrieder N; Wagner R; Brandmüller C; Schmidt P; Wolf H; Kaaden OR
Virology; 1995 Apr; 208(2):500-10. PubMed ID: 7747423
[TBL] [Abstract][Full Text] [Related]
6. Expression of membrane-bound and secreted forms of equine herpesvirus 1 glycoprotein D by recombinant baculovirus.
Flowers CC; Flowers SP; Sheng Y; Tarbet EB; Jennings SR; O'Callaghan DJ
Virus Res; 1995 Jan; 35(1):17-34. PubMed ID: 7754672
[TBL] [Abstract][Full Text] [Related]
7. Immune responses and protective efficacy of recombinant baculovirus-expressed glycoproteins of equine herpesvirus 1 (EHV-1) gB, gC and gD alone or in combinations in BALB/c mice.
Packiarajah P; Walker C; Gilkerson J; Whalley JM; Love DN
Vet Microbiol; 1998 Apr; 61(4):261-78. PubMed ID: 9646476
[TBL] [Abstract][Full Text] [Related]
8. The expression of the proteins of equine herpesvirus 1 which share homology with herpes simplex virus 1 glycoproteins H and L.
Stokes A; Alber DG; Greensill J; Amellal B; Carvalho R; Taylor LA; Doel TR; Killington RA; Halliburton IW; Meredith DM
Virus Res; 1996 Jan; 40(1):91-107. PubMed ID: 8725124
[TBL] [Abstract][Full Text] [Related]
9. Equine herpesvirus 1 glycoprotein D expressed in Pichia pastoris is hyperglycosylated and elicits a protective immune response in the mouse model of EHV-1 disease.
Ruitenberg KM; Gilkerson JR; Wellington JE; Love DN; Whalley JM
Virus Res; 2001 Nov; 79(1-2):125-35. PubMed ID: 11551653
[TBL] [Abstract][Full Text] [Related]
10. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
[TBL] [Abstract][Full Text] [Related]
11. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.
Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG
J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of equine herpesvirus 1 glycoproteins expressed in insect cells.
Whalley JM; Love DN; Tewari D; Field HJ
Vet Microbiol; 1995 Sep; 46(1-3):193-201. PubMed ID: 8545956
[TBL] [Abstract][Full Text] [Related]
13. A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naïve and infection-primed mice.
Ruitenberg KM; Walker C; Love DN; Wellington JE; Whalley JM
Vaccine; 2000 Jan; 18(14):1367-73. PubMed ID: 10618534
[TBL] [Abstract][Full Text] [Related]
14. Expression of equine herpesvirus 1 glycoprotein D by using a recombinant baculovirus.
Love DN; Bell CW; Pye D; Edwards S; Hayden M; Lawrence GL; Boyle D; Pye T; Whalley JM
J Virol; 1993 Nov; 67(11):6820-3. PubMed ID: 8411384
[TBL] [Abstract][Full Text] [Related]
15. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
[TBL] [Abstract][Full Text] [Related]
16. Expression and characterisation of equine herpesvirus 1 glycoprotein H using a recombinant baculovirus.
McGowan EM; Hayden MB; Edwards SJ; Pye D; Love DN; Whalley JM
Arch Virol; 1994; 137(3-4):389-95. PubMed ID: 7944958
[TBL] [Abstract][Full Text] [Related]
17. EHV-1 glycoprotein D (EHV-1 gD) is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice.
Csellner H; Walker C; Wellington JE; McLure LE; Love DN; Whalley JM
Arch Virol; 2000; 145(11):2371-85. PubMed ID: 11205124
[TBL] [Abstract][Full Text] [Related]
18. Study of the protective immunity of co-expressed glycoprotein H and L of equine herpesvirus-1 in a murine intranasal infection model.
Kukreja A; Love DN; Whalley JM; Field HJ
Vet Microbiol; 1998 Feb; 60(1):1-11. PubMed ID: 9595623
[TBL] [Abstract][Full Text] [Related]
19. TLR-5 agonist Salmonella abortus equi flagellin FliC enhances FliC-gD-based DNA vaccination against equine herpesvirus 1 infection.
Zhao Y; Chang J; Zhang B; Tong P; Wang C; Ran D; Su Y
Arch Virol; 2019 May; 164(5):1371-1382. PubMed ID: 30888564
[TBL] [Abstract][Full Text] [Related]
20. Solid matrix-antibody-antigen complexes incorporating equine herpesvirus 1 glycoproteins C and D elicit anti-viral immune responses in BALB/c (H-2K(d)) and C3H (H-2K(k)) mice.
Alber DG; Killington RA; Stokes A
Vaccine; 2000 Nov; 19(7-8):895-901. PubMed ID: 11115713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
